Elevated creatine phosphokinase levels associated with the use of etretinate.
D000293:Adolescent; D003402:Creatine Kinase / Q000097:blood*; D005050:Etretinate / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007645:Keratoderma, Palmoplantar / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy
D005050:Etretinate; D003402:Creatine Kinase